Compounds having a structure of Formula I: wherein G, a, Q, L
2
, R
1
, R
2
, R
3
, R
4
, R
5
and R
6
are as defined herein are provided. Uses of such compounds for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are also provided.